Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company developing therapies to target hypertension and related comorbidities such as chronic kidney disease (CKD), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback